Clinical and Molecular Hepatology

Scope & Guideline

Transforming the landscape of hepatology with cutting-edge studies.

Introduction

Explore the comprehensive scope of Clinical and Molecular Hepatology through our detailed guidelines, including its aims and scope. Stay updated with trending and emerging topics, and delve into declining areas to understand shifts in academic interest. Our guidelines also showcase highly cited topics, featuring influential research making a significant impact. Additionally, discover the latest published papers and those with high citation counts, offering a snapshot of current scholarly conversations. Use these guidelines to explore Clinical and Molecular Hepatology in depth and align your research initiatives with current academic trends.
LanguageEnglish
ISSN2287-2728
PublisherKOREAN ASSOC STUDY LIVER
Support Open AccessYes
CountrySouth Korea
TypeJournal
Convergefrom 2012 to 2024
AbbreviationCLIN MOL HEPATOL / Clin. Mol. Hepatol.
Frequency4 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressRM A1210, 53 MAPO-DAERO, MAPOTRAPALACE, DOWHA-DONG, MAPO-GU, SEOUL 04158, SOUTH KOREA

Aims and Scopes

The journal 'Clinical and Molecular Hepatology' focuses on advancing research and clinical practices related to liver diseases. It aims to disseminate significant findings that contribute to the understanding, diagnosis, treatment, and prevention of various hepatobiliary conditions.
  1. Hepatitis B and C Virus Research:
    A major focus on the molecular mechanisms, therapeutic strategies, and clinical outcomes related to hepatitis B and C infections, including studies on antiviral treatments, biomarkers, and patient management.
  2. Hepatocellular Carcinoma (HCC) Insights:
    Research dedicated to understanding the epidemiology, risk factors, prevention strategies, and treatment modalities for hepatocellular carcinoma, including surgical and non-surgical interventions.
  3. Metabolic Dysfunction-Associated Liver Diseases:
    Exploration of metabolic liver diseases, particularly the transition from non-alcoholic fatty liver disease (NAFLD) to metabolic dysfunction-associated steatotic liver disease (MASLD), and their clinical implications.
  4. Liver Transplantation and Regenerative Medicine:
    Studies focusing on advancement in liver transplantation techniques, donor-recipient matching, and the role of stem cells in liver regeneration and therapy.
  5. Clinical Guidelines and Real-World Practices:
    Dissemination of clinical practice guidelines and real-world evidence to improve management strategies and patient outcomes for liver diseases across diverse populations.
  6. Emerging Technologies in Hepatology:
    Incorporation of innovative methodologies such as machine learning and multi-omics approaches to enhance diagnostic accuracy and treatment efficacy in liver diseases.
The journal has identified several trending themes that are emerging as critical areas of interest in hepatology. These reflect the evolving landscape of liver disease research and clinical practice.
  1. Artificial Intelligence and Machine Learning Applications:
    The integration of AI and machine learning in predicting treatment outcomes and disease progression is on the rise, showcasing the potential for technology to enhance clinical decision-making.
  2. Multi-Omics Approaches:
    Research employing multi-omics profiling is gaining momentum, offering insights into the complex biological underpinnings of liver diseases and paving the way for personalized treatment strategies.
  3. Risk Stratification and Predictive Modeling:
    An increasing emphasis on developing risk scores and predictive models to identify high-risk patients for liver diseases, particularly in hepatocellular carcinoma and metabolic disorders.
  4. Patient-Centered Care in Liver Disease Management:
    A growing focus on patient-centered approaches that consider the individual needs and experiences of patients in the management of liver diseases, promoting better adherence and outcomes.
  5. Global Health Perspectives on Liver Diseases:
    Research that addresses the global burden of liver diseases, particularly in low- and middle-income countries, is gaining attention as the field recognizes the need for equitable healthcare access.

Declining or Waning

While the journal has seen significant growth in various research areas, certain scopes appear to be declining in prominence. This may reflect shifting priorities in the field or advancements in understanding that reduce the need for certain types of studies.
  1. Traditional Histological Techniques:
    There is a noticeable decrease in studies relying solely on traditional histological evaluations for liver diseases, as more non-invasive and advanced imaging techniques gain traction.
  2. Focus on Alcohol-Related Liver Disease:
    Research specifically targeting alcohol-related liver disease seems to be less frequent as the focus shifts towards metabolic and viral liver diseases, which are becoming more prevalent.
  3. Single-Agent Therapeutics:
    The exploration of single-agent therapies for liver diseases is waning in favor of combination therapies and personalized medicine approaches that consider patient-specific factors.
  4. Non-viral Hepatitis Research:
    Research on non-viral forms of hepatitis has seen a decline, likely overshadowed by the urgent need to address viral hepatitis and its associated complications.

Similar Journals

Clinics in Liver Disease

Connecting researchers and clinicians for liver health advancements.
Publisher: W B SAUNDERS CO-ELSEVIER INCISSN: 1089-3261Frequency: 4 issues/year

Clinics in Liver Disease is an esteemed peer-reviewed journal published by W B Saunders Co-Elsevier Inc, dedicated to advancing the field of hepatology. Established in 1997 and covering a broad range of topics within liver disease research, this journal serves as a vital resource for researchers, clinicians, and students engaged in the study of liver health and diseases. With a commendable impact factor placing it within the Q2 category in Hepatology and ranking #32 out of 82 in the Scopus classifications, it consistently disseminates high-quality research and clinical insights. The journal’s commitment to promoting understanding and management of liver diseases is reflected in its rigorous editorial standards and comprehensive review processes. Although not an open-access publication, Clinics in Liver Disease offers subscription options that ensure accessibility to up-to-date research and reviews critical for both academic and clinical success.

Hepatology Communications

Transforming liver research into impactful care.
Publisher: LIPPINCOTT WILLIAMS & WILKINSISSN: Frequency: 12 issues/year

Hepatology Communications, published by Lippincott Williams & Wilkins, serves as a pioneering platform in the field of hepatology, dedicated to advancing the understanding of liver diseases and treatments. Since its inception in 2017, this open access journal has rapidly gained recognition, achieving an impressive Q1 ranking in Hepatology as of 2023, and appealing to a diverse audience of researchers, clinicians, and students alike. With its focus on high-quality research and clinical studies, the journal aims to facilitate impactful discussions and disseminate vital findings that address the challenges faced in liver health. Operating out of the United States, and accessible globally, Hepatology Communications is committed to fostering a collaborative research environment and enhancing the visibility of scholarly work in hepatology, ultimately driving forward innovations in patient care and treatment strategies.

HEPATOLOGY RESEARCH

Bridging research and practice for improved patient outcomes.
Publisher: WILEYISSN: 1386-6346Frequency: 12 issues/year

Hepatology Research, ISSN 1386-6346 and E-ISSN 1872-034X, is a premier academic journal published by Wiley that serves the dynamic fields of Hepatology and Infectious Diseases. With an impressive 2023 impact factor and ranked Q2 in Hepatology and Q1 in Infectious Diseases, this journal stands out as a vital resource for researchers, professionals, and students. Covering a broad spectrum of topics related to liver health, the journal aims to disseminate cutting-edge research and insights from the converged years of 1997 to 2024. As an open-access platform, it fosters the global sharing of knowledge, providing valuable access to pioneering studies that address pressing issues in liver disease and its associated infections. Based in the United Kingdom, at 111 River St, Hoboken, NJ, Hepatology Research is pivotal for advancing scientific understanding and improving patient outcomes worldwide.

Liver Cancer

Fostering collaboration in the fight against liver cancer.
Publisher: KARGERISSN: 2235-1795Frequency: 6 issues/year

Liver Cancer is a premier, peer-reviewed journal dedicated to the comprehensive study and advancement of knowledge surrounding liver neoplasms. Published by KARGER and headquartered in Switzerland, this journal has been an open-access platform since 2012, providing researchers with invaluable insights into the rapidly evolving field of hepatology and oncology. With an impressive impact factor that places it in the Q1 category for both Hepatology and Oncology in 2023, Liver Cancer stands out as a high-impact conduit for groundbreaking research, ranking #19 out of 404 in Medicine _ Oncology and #6 out of 82 in Medicine _ Hepatology according to Scopus. Researchers, practitioners, and students are encouraged to engage with the journal's content, which encompasses clinical studies, basic research, and reviews that contribute significantly to understanding liver cancer dynamics, diagnosis, and treatment strategies. This journal not only facilitates the dissemination of knowledge but also fosters collaboration in a well-established and impactful global scientific community.

JOURNAL OF HEPATOLOGY

Leading the Way in Hepatic Health Discoveries
Publisher: ELSEVIERISSN: 0168-8278Frequency: 12 issues/year

JOURNAL OF HEPATOLOGY, published by Elsevier, stands as a preeminent source in the field of Hepatology, with its impact underscored by a remarkable 2023 Category Quartile of Q1 and a Scopus rank of 3rd out of 82 journals, placing it in the 96th percentile for the discipline. Since its inception in 1985, this journal has been a vital conduit for the dissemination of pioneering research, clinical studies, and reviews related to liver diseases and their impact on global health. Although it currently does not offer open access options, the journal is committed to providing top-tier content to its readership—researchers, medical professionals, and students—in order to advance knowledge and foster innovation in hepatology. With a broad and inclusive scope, it aims to cover significant breakthroughs, therapeutic advancements, and epidemiological studies, continually pushing the boundaries of understanding in liver health. The journal is based in Amsterdam, Netherlands, and remains an essential resource for those dedicated to the progression of hepatologic science.

Clinical and Experimental Hepatology

Uncovering New Horizons in Hepatology
Publisher: TERMEDIA PUBLISHING HOUSE LTDISSN: 2392-1099Frequency: 4 issues/year

Clinical and Experimental Hepatology is a pivotal journal dedicated to advancing the field of hepatology, providing a platform for researchers, clinicians, and students to disseminate and explore groundbreaking findings. Published by TERMEDIA PUBLISHING HOUSE LTD in Poland, this journal serves as a vital resource for professionals seeking to enhance their knowledge and contributions in the realm of liver diseases and their management. With an impact factor reflective of its growing influence—ranking Q3 in Hepatology for the year 2023 and holding the 49th position out of 82 in Scopus Medicine Hepatology ranks—this publication underscores the significance of innovative research in this specialized domain. While it currently operates through a subscription model rather than open access, it bridges the gap in hepatological literature by featuring a diverse array of scholarly articles, case reports, and reviews from 2015 to 2024. Researchers and health professionals alike will find valuable insights that can enhance clinical practice and inform future studies, solidifying its importance in the hepatology community.

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY

Innovative insights into digestive and liver health.
Publisher: WILEYISSN: 0815-9319Frequency: 12 issues/year

Welcome to the JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, an esteemed publication in the field of gastroenterology and hepatology, proudly published by WILEY. Established in 1986, this journal serves as a crucial platform for researchers, healthcare professionals, and students, presenting groundbreaking research and comprehensive reviews that drive advances in understanding and treating gastrointestinal and liver diseases. With a strong reputation evidenced by its Q1 ranking in gastroenterology and Q2 ranking in hepatology, this journal ranks impressively in the Scopus metrics - positioned at #22 out of 167 in gastroenterology and #21 out of 82 in hepatology, reflecting its contribution to scholarly excellence. Although it does not offer open access options, the journal’s rich archive and diverse topics make it indispensable for those dedicated to improving patient outcomes in these critical areas of medicine. Whether you are a seasoned researcher or an aspiring medical professional, engaging with this journal will keep you at the forefront of the latest developments and emerging trends in gastroenterology and hepatology research.

Hepatology International

Innovating hepatology for a healthier tomorrow.
Publisher: SPRINGERISSN: 1936-0533Frequency: 4 issues/year

Hepatology International is a premier academic journal dedicated to advancing the field of liver research and hepatology. Published by SPRINGER, this journal boasts a prestigious Q1 ranking in Hepatology as of 2023, underscoring its commitment to high-quality research dissemination. The journal’s scope encompasses a wide range of topics related to liver disease, including clinical, translational, and basic science studies. With its impact factor reflecting its relevance and influence in the field, Hepatology International serves as an essential resource for researchers, clinicians, and students aiming to keep abreast of the latest developments and breakthroughs. Though traditionally a subscription-based journal, it offers a vast array of insightful articles that contribute significantly to our understanding of hepatological conditions. The journal continues its trajectory of growth since its inception in 2008, anticipating a convergence of knowledge and innovation through to 2024. Located in the heart of New York City, this journal not only represents a crucial platform for global hepatology research but also fosters a collaborative community of experts dedicated to improving liver health worldwide.

REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS

Exploring innovative solutions in gastroenterology.
Publisher: ARAN EDICIONES, S AISSN: 1130-0108Frequency: 12 issues/year

REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS, a pivotal Open Access journal published by ARAN EDICIONES, S A, has been at the forefront of advancing the field of gastroenterology since its inception in 1990. With a robust commitment to disseminating high-quality research, the journal provides a platform for researchers, clinicians, and students to share innovative findings and insights concerning digestive diseases. The journal is characterized by its Q3 ranking in both Gastroenterology and Miscellaneous Medicine categories, indicative of its significant contributions to these fields, and is positioned within the 36th percentile of Scopus rankings for medicine related to gastroenterology. Based in Spain, REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS has embraced the Open Access model since 2004, ensuring that its articles are readily available to a global audience without financial barriers. The journal not only supports academic discourse but also plays a crucial role in improving clinical practices and health outcomes related to digestive health.

Saudi Journal of Gastroenterology

Fostering innovation in clinical gastroenterology.
Publisher: WOLTERS KLUWER MEDKNOW PUBLICATIONSISSN: 1319-3767Frequency: 6 issues/year

The Saudi Journal of Gastroenterology is a premier platform dedicated to advancing research and clinical practice in the field of gastroenterology. Published by Wolters Kluwer Medknow Publications, this open-access journal has been serving the academic community since 1995 from its base in India. With an ISSN of 1319-3767 and an E-ISSN of 1998-4049, the journal allows unrestricted access to a wealth of knowledge, fostering an environment where researchers, professionals, and students can engage with cutting-edge studies. As of 2023, it is categorized in the Q3 quartile within gastroenterology, ranking #74 out of 167 in Scopus, which places it within the 55th percentile of its field. The journal aims to disseminate significant findings, clinical trials, and innovative theories that shape the understanding of gastrointestinal disorders and practices. With a commitment to quality and relevance, the Saudi Journal of Gastroenterology is pivotal for anyone seeking to enhance their knowledge and expertise in this vital area of medicine.